Skip to main content
logo
BridgeBio Pharma, Inc. (FRA:2CL)
Germany flag Germany · Delayed Price · Currency is EUR
63.52
-1.44 (-2.22%)
Last updated: Jan 28, 2026, 3:58 PM CET

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Transformative Medicines
221.90M
Transformative Medicines Growth
2285.27%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
EMEA
132.03M
APAC
76.56M
North America
13.31M